The stability of HIF-1α and the translocation of the α subunit to the nucleus to bind to HIF-1β is reduced, resulting in the decrease of its ability to activate the cancer-promoting target genes glucose transporter 1 and carbonic anhydrase IX, exerting the role of inhibiting liver cancer progression (85–87). This evidence concerns the gene HIF1A and cancer.